Thursday, 17 August 2017

Biologics News

  • Hospira recalls plum infusion pump for over blood delivery risk

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 19 Mar, 2014

    Singapore: FDA has stated that biologic drug company, Hospira, has identified an incorrect set component supplied and used during the manufacturing process of Hemostat Dual Channel Plum Set...Read more

  • Pharmaxis, Synairgen to develop drugs for fatal lung disease

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 06 Aug, 2015

    Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a research collaboration to develop a selective inhibitor to the lysyl oxi...Read more

  • BioTime appoints Adi Mohanty as COO

    Biologics |  Influencers | By BioSpectrum Bureau | 0 Comment | 30 Dec, 2014

    Singapore: Stem cell therapy company, BioTime, has appointed Mr Adi Mohanty, ex-Shire executive, as chief operating officer and would be reponsible to build BioTime's business through the d...Read more

  • Baxter inaugurates biologics facility in Singapore

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2014

    Singapore: Baxter International has launched an advanced recombinant biologic facility in Singapore. The suite supports the processing of ADVATE [Antihemophilic Factor (Recombinant)], full...Read more

  • Baxter recalls dialysis solution

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Aug, 2014

    Singapore: Baxter is voluntarily initiating a recall of two lots of DIANEAL Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) to the hospital/user lev...Read more

  • CFDA approves peripheral T-cell lymphoma drug

    Biologics |  Regulatory | By BioSpectrum Bureau | 0 Comment | 12 Jan, 2015

    ‎Singapore: Chinese Food and Drug Administration (CFDA) has approved Chidamide (Epidaza), an orally administrated and subtype-selective histone deacetylase (HDAC) inhibitor for relaps...Read more

  • Austrianova's encapsulated cell to treat pancreatic cancer

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 14 Aug, 2014

    Singapore: Singapore-based Austrianova's encapsulated cell technology has demonstrated to treat pancreatic cancer in a phase 2 study, according to a paper published in Biotech Journal Pharm...Read more

  • New testing kit fast tracks Ebola diagnosis

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 03 Sep, 2014

    Singapore: Japanese researchers at the Nagasaki University announced that they have developed a new diagnostic technique that can detect the deadly Ebola virus infection in 30 minutes. This...Read more

  • Implantable device to regulate insulin in Diabetics

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2014

    Singapore: In a bid to provide relief to the millions of insulin injecting patients, bioengineers from Basel have developed new implantable device that can monitor acid build-up in diabetic...Read more

  • Dr Gautam Daftary: The Indian biologics pioneer

    Biologics |  Influencers | By Manasi Vaidya | 0 Comment | 14 Feb, 2013

    Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world and has carved out a prominent space in the world of biologicals and...Read more

  • China Biologic raises equity share to 76%

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Sep, 2014

    Singapore: China Biologic Products has acquired an additional 19.84 percent equity interest in Guizhou Taibang Biological Products, raising shares from 56.39 percent to 76.23 percent. Chin...Read more

  • German, Korean firm join hands to discover cancer drugs

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 04 Jun, 2015

    Singapore: Germany's translational drug discovery organization, Lead Discovery Center (LDC), has entered into a licence deal with Korea's Qurient for exclusive worldwide rights to a series ...Read more

  • Lonza to invest $15 mn in antibody manufacturing

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013

    Singapore: Lonza plans to invest $15.07 million (S$18.5 million) to expand its antibody drug conjugate (ADC) manufacturing capacity in Switzerland. Oncology therapeutics, including ADCs, re...Read more

  • WuXi AppTec invests $120mn to build new biologics facility

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016

    Singapore: WuXi AppTec has started construction of an integrated biologics solution center at the company's headquarters in Shanghai with a total investment plans of $120 million. The faci...Read more

  • Aussie firm's new breakthrough in bladder cancer

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 10 Jan, 2015

    Singapore: Australia-based startup company Sienna Cancer Diagnostics, has inked a pact with an American pathology company, Bostwick Laboratories, to commercialize world's first bladder canc...Read more

  • Austrianova inaugurates its Thailand facility

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 15 Dec, 2014

    Singapore: Austrianova, a Singapore-based cell-encapsulation company recently announced the opening of its manufacturing facility at Thailand Science Park, Bangkok. The inauguration ceremon...Read more

  • Israel firm gets US, China patent for neuro-peptide

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013

    Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a synthetic therapeutic peptide, in thromboembolic diseases and pathol...Read more

  • Singapore scientists find new clues on cervical cancer

    Biologics |  News | By BioSpectrum Bureau | 0 Comment | 09 Dec, 2015

    Singapore: A team of scientists from Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has uncovered new molecular interactions involved in...Read more

Orchard Therapeutics appoin...

Survey Box

Does Asia have more to offer to the global 3D cell culture market?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls